Production and characterization of recombinant factor VIII.
作者信息
Klein U
机构信息
Cutter Biological, Miles Inc, Berkeley, CA 94710.
出版信息
Semin Hematol. 1991 Apr;28(2 Suppl 1):17-21.
PMID:1908121
Abstract
摘要
相似文献
1
Production and characterization of recombinant factor VIII.
Semin Hematol. 1991 Apr;28(2 Suppl 1):17-21.
2
Genetic characterization of recombinant BHK-21 cells expressing factor VIII.表达凝血因子VIII的重组BHK-21细胞的遗传特征分析
Semin Hematol. 1991 Apr;28(2 Suppl 1):10-6.
3
Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.生物技术与血浆分馏行业——凝血因子VIII生产进展的影响
Australas Biotechnol. 1993 Jan-Feb;3(1):16-20.
4
Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.使用表面等离子体共振生物传感器筛选的抗凝血因子VIII单克隆抗体纯化重组人B结构域缺失的凝血因子VIII
Biotechnol Prog. 2001 Nov-Dec;17(6):1119-27. doi: 10.1021/bp010100o.
5
[Recombinant factor VIII].[重组凝血因子 VIII]
Sangre (Barc). 1993 Apr;38(2):139-42.
6
Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII.使用肽配体的亲和色谱步骤用于cGMP生产因子VIII的方法开发与验证。
Biotechnol Bioeng. 2004 Aug 5;87(3):400-12. doi: 10.1002/bit.20124.
7
Characterization of recombinant BHK-21 endogenous particles: R-type particles.
Biologicals. 1994 Jun;22(2):121-5. doi: 10.1006/biol.1994.1018.
8
9
Cell culture and purification process--purity and safety testing.细胞培养与纯化过程——纯度与安全性检测。
Ann Hematol. 1994;68 Suppl 3(Suppl 3):S15-20. doi: 10.1007/BF01774524.
10
Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
Semin Hematol. 1991 Apr;28(2 Suppl 1):44.
Zotero 插件